Cover Image

Reproductive and endocrine effects of artemisinin, piperaquine, and artemisinin-piperaquine combination in rats

Abstract Background: The WHO recommends artemisinin-based combination regimens for uncomplicated Plasmodium falciparum malaria. One such combination is artemisinin-piperaquine tablets (ATQ). ATQ has outstanding advantages in anti-malarial, such as good efficacy, fewer side effects, easy promotion an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaobo Li (Author), Yueming Yuan (Author), Yingyi Chen (Author), Li Ru (Author), Zheng Yuan (Author), Zhiyong Xu (Author), Qin Xu (Author), Jianping Song (Author), Guoming Li (Author), Changsheng Deng (Author)
Format:	Book
Published:	BMC, 2022-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and Safety of Artemisinin-Piperaquine for the Treatment of Uncomplicated Malaria: A Systematic Review
by: Qi Wang, et al.
Published: (2020)

Surveillance of the Efficacy of Artemisinin-Piperaquine in the Treatment of Uncomplicated Plasmodium falciparum Malaria Among Children Under 5 Years of Age in Est-Mono District, Togo, in 2017
by: Qi Wang, et al.
Published: (2020)

The Effect of Artemisinin-Based Drugs vs Non-artemisinin-based Drugs on Gametophyte Carrying in the Body After the Treatment of Uncomplicated Falciparum Malaria: A Systematic Review and Meta-analysis
by: Yuanyuan Zou, et al.
Published: (2022)

Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics
by: David Dolivo, et al.
Published: (2021)

Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections
by: Junjie Ding, et al.
Published: (2024)

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of <i>Schistosoma mansoni</i> Infection
by: Omary Mashiku Minzi, et al.
Published: (2021)

Artemisinin: A Panacea Eligible for Unrestrictive Use?
by: Dong-Sheng Yuan, et al.
Published: (2017)

Efficacy and safety of dihydroartemisinin-piperaquine in Indonesian children infected with uncomplicated Plasmodium falciparum and Plasmodium vivax
by: Emiliana Tjitra, et al.
Published: (2011)

Artemisinin-Naphthoquine Combination (ARCO®): An Overview of the Progress
by: Qingyun Huang, et al.
Published: (2010)

Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial.
by: Rajabu Hussein Mnkugwe, et al.
Published: (2020)

Superiority trial of intermittent treatment with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy
by: Roland Nnaemeka Okoro, et al.
Published: (2023)

Artemisinin - From Traditional Chinese Medicine to Artemisinin Combination Therapies; Four Decades of Research on the Biochemistry, Physiology, and Breeding of Artemisia annua
Published: (2020)

Acute and subacute oral toxicity assessment of Gancao Xiexin decoction in Sprague-Dawley rats
by: Li Ru, et al.
Published: (2023)

Anti-Inflammatory and Immunoregulatory Functions of Artemisinin and Its Derivatives
by: Chenchen Shi, et al.
Published: (2015)

Discovery of artemisinin: The Chinese wonder drug
by: Padmaja Udaykumar
Published: (2014)

Discovery of artemisinin: The Chinese wonder drug
by: Padmaja Udaykumar
Published: (2014)

Artemisinin anti-malarial drugs in China
by: Zongru Guo
Published: (2016)

Safety, pharmacokinetics and efficacy of artemisinins in pregnancy
by: Veronica Ades
Published: (2011)

Intermittent preventive treatment with sulphadoxine-pyrimethamine but not dihydroartemisinin-piperaquine modulates the relationship between inflammatory markers and adverse pregnancy outcomes in Malawi.
by: Kaylene Cheng, et al.
Published: (2024)

Efficacy and Safety of Qinghao Biejia Decoction in the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
by: Xiaobo Li, et al.
Published: (2021)

Pyrvinium pamoate can overcome artemisinin's resistance in anaplastic thyroid cancer
by: Yitian Li
Published: (2021)

Randomized, placebo‐controlled, double‐blind phase I trial of co‐administered pyronaridine and piperaquine in healthy adults of sub‐Saharan origin
by: Andrea Kuemmerle, et al.
Published: (2024)

Artemisinin-resistant malaria and a prevention strategy
by: Francis M Malwal
Published: (2020)

Artemisia scoparia - A new source of artemisinin
by: Aditi Singh, et al.
Published: (2010)

Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19)
by: Yexiao Tang, et al.
Published: (2022)

Long-term effects of increased adoption of artemisinin combination therapies in Burkina Faso
by: Robert J. Zupko, et al.
Published: (2022)

Long-term effects of increased adoption of artemisinin combination therapies in Burkina Faso.
by: Robert J Zupko, et al.
Published: (2022)

Optimum population-level use of artemisinin combination therapies: a modelling study
by: Tran Dang Nguyen, BSc, et al.
Published: (2015)

Therapeutic potential of artemisinin and its derivatives in managing kidney diseases
by: Qi Jin, et al.
Published: (2023)

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
by: Lorenz von Seidlein, et al.
Published: (2020)

Malaria profiles and challenges in artemisinin resistance containment in Myanmar
by: Thet Wai Nwe, et al.
Published: (2017)

The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease
by: Ming Xia, et al.
Published: (2020)

Artemisinin resistance and malaria elimination: Where are we now?
by: Borimas Hanboonkunupakarn, et al.
Published: (2022)

Characterisation of populations at risk of sub-optimal dosing of artemisinin-based combination therapy in Africa.
by: Abena Takyi, et al.
Published: (2023)

Characterisation of populations at risk of sub-optimal dosing of artemisinin-based combination therapy in Africa
by: Abena Takyi, et al.
Published: (2023)

Keeping ahead of the resistance curve: product bundling to conserve artemisinin-based combination therapy
by: Osman A Dar, et al.
Published: (2015)

Differential infectivity of gametocytes after artemisinin-based combination therapy of uncomplicated falciparum malaria
by: Dinkorma T. Ouologuem, et al.
Published: (2018)

Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs
by: Ho Ning Wong, et al.
Published: (2020)

Increasing use of artemisinin-based combination therapy for treatment of malaria infection in Nigerian hospitals
by: Igboeli NU, et al.
Published: (2010)

New clinical application prospects of artemisinin and its derivatives: a scoping review
by: Yangmu Huang, et al.
Published: (2023)